映恩生物拟在上交所科创板上市

Core Viewpoint - The company, Ying'en Biotechnology (09606.HK), announced its decision to propose the issuance of RMB shares and listing on the Shanghai Stock Exchange's Sci-Tech Innovation Board, contingent upon market conditions and necessary approvals [1] Group 1 - The board of directors has made a resolution regarding the issuance of shares [1] - The listing is subject to further approval from the board, shareholders, and regulatory authorities [1]